Related Experiment Video
Updated: Jul 13, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Insulin resistance in Hispanic large-for-gestational-age neonates at birth
Jennifer Shine Dyer1, Charles R Rosenfeld, Julie Rice
1Department of Pediatrics, Division of Endocrinology, The Ohio State University, 700 Children's Drive, W322, Columbus, Ohio 43205, USA. dyerj@pediatrics.ohio-state.edu
Insights
Reduced insulin sensitivity is present at birth in large Hispanic newborns, indicating insulin resistance may begin before birth. This suggests altered fetal programming in response to maternal diabetes or large size.
Area of Science:
- Perinatology
- Neonatal Metabolism
- Endocrinology
Background:
- Maternal diabetes and macrosomia are known risk factors for insulin resistance and metabolic syndrome.
- Hispanic youth exhibit high metabolic syndrome prevalence, but neonatal metabolic status is unclear.
- This study investigates early metabolic changes in at-risk Hispanic neonates.
Purpose of the Study:
- To determine if insulin sensitivity abnormalities exist at or shortly after birth in large-for-gestational-age (LGA) neonates born to Hispanic women.
- To compare insulin sensitivity in LGA neonates born to mothers with and without gestational diabetes.
- To assess if early signs of insulin resistance are present in utero.
Main Methods:
- Cross-sectional study of 42 term Hispanic neonates within 48 hours of birth.
- Groups included LGA neonates of mothers with gestational diabetes (LGA-IDM), LGA neonates of mothers without gestational diabetes (LGA-non-IDM), small-for-gestational-age, and appropriate-for-gestational-age controls.
- Insulin sensitivity and secretion were measured using a shortened fasting intravenous glucose tolerance test.
Main Results:
- All neonates were euglycemic at the time of study.
- Insulin sensitivity was significantly lower in LGA-IDM and LGA-non-IDM neonates compared to controls.
- No significant differences in insulin secretion were observed between the groups.
Conclusions:
- Reduced insulin sensitivity is evident shortly after birth in Hispanic LGA neonates, regardless of maternal gestational diabetes status.
- This suggests the onset of insulin resistance occurs before birth.
- Findings indicate altered fetal programming contributing to metabolic abnormalities.
Content:
Intrauterine exposure to maternal diabetes and large size at birth are known risk factors for the subsequent development of insulin resistance and metabolic syndrome. Although Hispanic youth have been shown to have a high prevalence of metabolic syndrome, it is unknown whether metabolic abnormalities and a predisposition for glucose intolerance are present at birth.
Objective:
The objective of the study was to determine whether abnormalities in insulin sensitivity exist at or soon after birth in large-for-gestational-age neonates born to Hispanic women with and without gestational diabetes. DESIGN/PATIENTS/SETTING: Forty-two term Hispanic neonates were enrolled for cross-sectional studies at 24-48 h after birth and included nine large-for-gestational-age neonates delivered of women with gestational diabetes (large-for-gestational-age-IDM), 12 large-for-gestational-age but not IDM neonates, 11 poorly grown (at the fifth to 10th percentile), and 10 appropriate-for-gestational-age neonates. Insulin sensitivity and secretion were measured by shortened fasting iv glucose tolerance test.
Main Outcome Measure:
Insulin sensitivity index was measured within 48 h of birth.
Results:
Neonates were studied at 36 +/- 11 h postnatally, and all groups were euglycemic at the time of study. However, insulin sensitivity was significantly lower (P < 0.05, ANOVA) in large-for-gestational-age-IDM [3.0 +/- 0.7 (sem) mU/liter.min] and large-for-gestational-age-non-IDM (2.2 +/- 0.4 mU/liter.min) cohorts in comparison with poorly grown (5.0 +/- 0.7 mU/liter.min) and appropriate-for-gestational-age controls (5.4 +/- 0.8 mU/liter.min). Insulin secretion did not differ between groups.
Conclusions:
Reduced insulin sensitivity is present soon after birth in Hispanic large-for-gestational-age neonates born to mothers with and without gestational diabetes, demonstrating the onset of insulin resistance before birth and evidence of altered fetal programming.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Diabetes Mellitus: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
